Skip to main content

Table 1 Characteristics of the controls, IPF and COPD patients in the 2-DE analyses of the lung homogenates

From: Hemoglobin α and β are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD

 

Control

COPD

Stage IV

IPF

Patients, n

4

4

4

Age, yr

59 ± 7

58 ± 4

54 ± 5

Sex, M/F

3/1

1/3

3/1

Pack years, yr

< 12 *

32 ± 2***

15**

FEV1 (%)

89 ± 10

12 ± 2***

38 ± 3***

FVC (%)

77 ± 1

31 ± 4 ***

35 ± 3***

  1. Data are presented as mean ± SEM.
  2. * Three of the controls were never smokers and one of the controls had smoked 10 to 12 years but stopped smoking at least 2 years before the study.
  3. ** Three of the IPF patients were never smokers and one of the IPF patients had smoked but stopped smoking 30 years before the surgery.
  4. *** p < 0.05 versus control subjects. All patients with COPD stage IV had been smoked but stopped smoking at least 2 years before the study.